49,499 Shares in Astera Labs, Inc. $ALAB Purchased by EFG International AG

EFG International AG acquired a new position in Astera Labs, Inc. (NASDAQ:ALABFree Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 49,499 shares of the company’s stock, valued at approximately $23,883,000.

Several other large investors have also modified their holdings of ALAB. Vanguard Group Inc. raised its holdings in shares of Astera Labs by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after buying an additional 84,365 shares during the period. BlackRock Inc. bought a new stake in shares of Astera Labs during the 2nd quarter worth approximately $6,609,581,000. Atreides Management LP boosted its holdings in Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after acquiring an additional 1,754,593 shares during the period. State Street Corp boosted its holdings in Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after acquiring an additional 760,358 shares during the period. Finally, Geode Capital Management LLC grew its position in Astera Labs by 4.5% in the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after acquiring an additional 104,935 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Trading Up 1.8%

Shares of Astera Labs stock opened at $282.65 on Wednesday. The stock’s fifty day moving average price is $348.88 and its 200-day moving average price is $247.38. The firm has a market cap of $49.04 billion, a P/E ratio of 139.93 and a beta of 3.84. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same period in the prior year, the firm earned $0.44 earnings per share. The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts forecast that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Morgan Stanley increased their target price on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Weiss Ratings reissued a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. Citigroup restated a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. Susquehanna raised their price target on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Finally, Stifel Nicolaus lifted their price objective on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and an average price target of $333.00.

Check Out Our Latest Stock Report on ALAB

Insiders Place Their Bets

In other news, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the transaction, the director directly owned 3,970 shares in the company, valued at approximately $1,237,965.10. The trade was a 69.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 419,244 shares of company stock worth $163,135,169. 10.40% of the stock is owned by corporate insiders.

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Recommended Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.